Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, today announced a strategic collaboration with the German Center for Neurodegenerative Diseases.
Alamar Biosciences,is proud to announce its commercial presence in the?Asia Pacific region with the installation of the ARGO? HT System, an advanced ultra-sensitive proteomics platform, at the prestigious Hong Kong Center for Neurodegenerative Diseases.